Baclofen (CAS NO : 1134-47-0)

Baclofen (CAS 1134-47-0) serves as a cornerstone in the United States API intermediates market, where its role as a high-purity fine chemical is essential for the domestic manufacture of muscle relaxants targeting spasticity associated with multiple sclerosis and spinal cord injuries. 4-Amino-3-(4-chlorophenyl)butanoic acid is increasingly sourced through specialized custom synthesis services by North American CDMOs who are prioritizing domestic supply chain resilience and cGMP compliance to mitigate risks from global sourcing shifts and meet rigorous FDA standards for Pharma/API purity 99%. beta-(Aminomethyl)-4-chlorobenzenepropanoic acid also finds critical utility as a general industry purity 98% building block for advanced neurological research and neuropharmacological diagnostic tools, driving sustained demand for a reliable bulk chemical supplier capable of providing exhaustive technical documentation and meeting American Chemical Society analytical benchmarks. We are an established Baclofen intermediates supplier with >= 99% purity in the united states, ensuring minimal carry-over of impurities in the final API, and a broad range of various pharmaceutical intermediates for API manufacturers and finished formulators, providing comprehensive analytical (HPLC/NMR/MS) and supporting Baclofen COA/TDS/SDS region-specific regulatory support, reliable lead times, worldwide supply chain capabilities